Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...
Advantmed, a leading provider of risk adjustment and Quality improvement solutions, today announced the launch of its Pay for Quality: HEDIS Abstraction offering--an industry-first, outcome-based ...
HEDIS 2018 season is right around the corner! Are you ready to learn from your 2017 programs and build metrics based 2018 quality improvement programs that deliver improved results across some 81 ...
Precise Word Matching AI outperforms machine learning AI to help payers close care gaps, improve Star Ratings, and advance patient outcomes Our Precise Word Matching AI guarantees compliant, accurate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results